Back to top

Image: Bigstock

Compared to Estimates, Ecolab (ECL) Q2 Earnings: A Look at Key Metrics

Read MoreHide Full Article

Ecolab (ECL - Free Report) reported $4.03 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 1%. EPS of $1.89 for the same period compares to $1.68 a year ago.

The reported revenue represents a surprise of +0.42% over the Zacks Consensus Estimate of $4.01 billion. With the consensus EPS estimate being $1.90, the EPS surprise was -0.53%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Ecolab performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Sales- Global Pest Elimination (Fixed Currency Rates): $311.3 million versus $309.06 million estimated by three analysts on average.
  • Sales-Global Water(Fixed currency): $1.91 billion versus $1.92 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -2.4% change.
  • Sales-Global Life Sciences (Fixed currency): $176.7 million versus the three-analyst average estimate of $179.14 million.
  • Sales- Global Institutional & Specialty (Fixed Currency rates): $1.51 billion compared to the $1.53 billion average estimate based on three analysts. The reported number represents a change of +10.1% year over year.
  • Sales- Global Life Sciences (Public Currency): $185.9 million versus $180.4 million estimated by two analysts on average.
  • Sales- Global Pest Elimination (Public Currency rates): $317.4 million versus $314.7 million estimated by two analysts on average.
  • Sales- Global Institutional & Specialty (Public Currency rates): $1.54 billion versus the two-analyst average estimate of $1.55 billion. The reported number represents a year-over-year change of +13.3%.
  • Sales-Global Water(Public Currency): $1.98 billion versus $2.01 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +2.1% change.
  • Operating Income- Global Life Sciences (Fixed currency): $34.8 million versus the three-analyst average estimate of $27.2 million.
  • Operating Income- Global Pest Elimination (Fixed Currency Rates): $61.2 million versus $60.41 million estimated by three analysts on average.
  • Operating Income- Global Institutional & Specialty (Fixed Currency rates): $359.4 million compared to the $360.94 million average estimate based on three analysts.
  • Operating Income- Corporate (Fixed currency rates): $-75 million compared to the $-48.9 million average estimate based on three analysts.

View all Key Company Metrics for Ecolab here>>>

Shares of Ecolab have returned +0.2% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Ecolab Inc. (ECL) - free report >>

Published in